38 filings
8-K
INZY
Inozyme Pharma Inc
7 May 24
Inozyme Pharma Reports First Quarter 2024 Financial Results and Provides Business Highlights
8:32am
8-K
INZY
Inozyme Pharma Inc
8 Apr 24
Inozyme Pharma Announces Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency (PXE) and ENPP1 Deficiency
6:44am
8-K
INZY
Inozyme Pharma Inc
12 Mar 24
Inozyme Pharma Reports Full Year 2023 Financial Results and Provides Business Highlights
8:32am
8-K
INZY
Inozyme Pharma Inc
7 Nov 23
Inozyme Pharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights
8:31am
8-K
INZY
Inozyme Pharma Inc
26 Sep 23
Regulation FD Disclosure
4:12pm
8-K
ewu788mf6jar
8 Aug 23
Inozyme Pharma Reports Second Quarter 2023 Financial Results and Provides Business Highlights
8:37am
8-K
o3o4fw32iu23fa38c 5n
28 Jul 23
Inozyme Pharma, Inc. Announces Pricing of Public Offering of Common Stock
5:19pm
8-K
e8y5bu583wzbs8cag
26 Jul 23
Inozyme Pharma Announces Updates on Global Development Strategy of INZ-701 for the Treatment of ENPP1 Deficiency
7:42am
8-K
9o4 g9zt2eykucac
27 Jun 23
Other Events
4:05pm
8-K
v71vbw4
14 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:36pm
8-K
td8ko6vpo3 7z4uf
9 May 23
Inozyme Pharma Reports First Quarter 2023 Financial Results and Provides Business Highlights
8:35am
8-K
liugsa56 5ov
22 Mar 23
Inozyme Pharma Reports Full Year 2022 Financial Results and Provides Business Highlights
8:35am
8-K
qdaw86vwn7
10 Mar 23
Regulation FD Disclosure
5:25pm
8-K
nw976 rprwv5gain0fbk
16 Feb 23
Inozyme Pharma Reports Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701
7:30am
8-K
p8tqyuu8861o1b hnm4
8 Dec 22
Departure of Directors or Certain Officers
4:14pm
8-K
f13jc
8 Dec 22
Other Events
7:31am
8-K
19143gh0z0f zr
10 Nov 22
Inozyme Pharma Reports Third Quarter 2022 Financial Results and Provides Business Updates
8:35am
8-K
oq5uiacs2 gwdypa
15 Aug 22
Inozyme Pharma Reports Second Quarter 2022 Financial Results and Provides Business Updates
7:36am
8-K
0dpc49ib5mr17ldepf2d
26 Jul 22
Entry into a Material Definitive Agreement
8:08am
8-K
ndprqw2mrmouxqly3hj
19 Jul 22
Regulation FD Disclosure
4:36pm